Your browser doesn't support javascript.
COVID-19 infection in Crohn's disease under treatment with adalimumab.
Tursi, Antonio; Angarano, Gioacchino; Monno, Laura; Saracino, Annalisa; Signorile, Fabio; Ricciardi, Aurelia; Papa, Alfredo.
  • Tursi A; Gastroenterology Service, Azienda Sanitaria Locale Barletta Andria Trani, Andria, Puglia, Italy antotursi@tiscali.it.
  • Angarano G; Division of Infectious Diseases, Bari University Hospital, University of Bari, Bari, Puglia, Italy.
  • Monno L; Division of Infectious Diseases, Bari University Hospital, University of Bari, Bari, Puglia, Italy.
  • Saracino A; Division of Infectious Diseases, Bari University Hospital, University of Bari, Bari, Puglia, Italy.
  • Signorile F; Division of Infectious Diseases, Bari University Hospital, University of Bari, Bari, Puglia, Italy.
  • Ricciardi A; Division of Infectious Diseases, Bari University Hospital, University of Bari, Bari, Puglia, Italy.
  • Papa A; Division of Internal Medicine and Gastroenterology, Complesso Integrato "Columbus", Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Roma, Lazio, Italy.
Gut ; 69(7): 1364-1365, 2020 07.
Article in English | MEDLINE | ID: covidwho-98813

Full text: Available Collection: International databases Database: MEDLINE Main subject: Crohn Disease / Coronavirus Limits: Humans Language: English Journal: Gut Year: 2020 Document Type: Article Affiliation country: Gutjnl-2020-321240

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Crohn Disease / Coronavirus Limits: Humans Language: English Journal: Gut Year: 2020 Document Type: Article Affiliation country: Gutjnl-2020-321240